Augusto Cesar Soares dos Santos Junior

Augusto Cesar Soares dos Santos Junior

Auto-generated profile, based on publicly available information

Augusto Cesar Soares dos Santos Junior

Faculdade de Ciências Médicas de Minas Gerais, Brazil; Universidade Federal de Minas Gerais, Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2014 in Birth Defects Research Part C: Embryo Today: Reviews
Verified
Journal Article
Closed access
PDF file
SJSoares dos Santos Junior
Soares dos Santos Junior
ACAugusto Cesar
Augusto Cesar
DMDebora De Miranda
Debora De Miranda
SSSimões e Silva
Simões e Silva
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva

1 February 2017 in International braz j urol
Verified
Journal Article
Open access
PDF file
AJAugusto Cesar Soares dos Santos Junior
Augusto Cesar Soares dos Santos Junior
BBBrasil Unimed Bh
Brasil Unimed Bh
LRLuíza de Oliveira Rodrigues
Luíza de Oliveira Rodrigues
DADaniela Castelo Azevedo
Daniela Castelo Azevedo
LCLélia Maria de Almeida Carvalho
Lélia Maria de Almeida Carvalho
SKSilvana Márcia Bruschi Kelles
Silvana Márcia Bruschi Kelles
This study aimed to retrospectively evaluate a cohort of patients with prostate cancer and persistent urinary incontinence after radical prostatectomy. From January 2004 to December 2015, eighty-six individuals were identified to have received an AUS implant, provided by a private nonprofit HMO operating in Belo Horizonte, Brazil. On total, there were 91 AUS implants, with a median interval between radical prostatectomy and AUS implant of 3.6 years (IQR 1.9 to 5.5). The rate of AUS cumulative survival, after a median follow-up of 4.1 years (IQR 1.7-7.2 years), was 44% (n=40). The median survival of AUS implants was 2.9 years (IQR 0.5-7.9 years). Thirty-seven AUS implants (40.7%) resulted in grade III surgical complications. There were 5 deaths at 2.1, 4.7, 5.7, 5.7 and 6.5 years of follow-up, but none due to causes directly associated to the AUS implant. Persistent severe incontinence was documented in 14 (15.3%) additional patients. From the 51 AUS implants which resulted in grade III surgical complications or persistent severe incontinence, 24 (47.1%) underwent surgical revisions. Explantation of the sphincter or its components was observed in 6 cases (25.0%). Mechanical failure, described as fluid loss and/or inability to recycle the AUS device, was observed in 4 devices (16.7%). In conclusion, although AUS implants are recommended as the gold-standard treatment of severe urinary incontinence after prostatectomy, the observed high rates of malfunction and grade III adverse events are a matter of concern warranting further assessment on the safety and efficacy of these devices.

19 February 2025 in Kidney International
Verified
Journal Article
Closed access
Joseph A. VassalottiJoseph A. Vassalotti
Joseph A. Vassalotti
AFAnna Francis
Anna Francis
ASAugusto Cesar Soares dos Santos
Augusto Cesar Soares dos Santos
RCRicardo Correa-Rotter
Ricardo Correa-Rotter
DADina Abdellatif
Dina Abdellatif
Vassilios LiakopoulosVassilios Liakopoulos
Vassilios Liakopoulos

4 July 2014 in Nephrology
Verified
Journal Article
Closed access
PDF file
DMDebora De Miranda
Debora De Miranda
ASAugusto Cesar dos Santos
Augusto Cesar dos Santos
HSHelena C Sarubi
Helena C Sarubi
LBLuciana Bastos‐Rodrigues
Luciana Bastos‐Rodrigues
DRDaniela Valadão Rosa
Daniela Valadão Rosa
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva

22 November 2019 in BMJ Evidence-Based Medicine
Verified
Journal Article
Closed access
PDF file
PGPeter J Gill
Peter J Gill
SAShabana M Ali
Shabana M Ali
YEYasmin Elsobky
Yasmin Elsobky
RORaymond C Okechukwu
Raymond C Okechukwu
TRTatiane B Ribeiro
Tatiane B Ribeiro
GRGeorgia C Richards
Georgia C Richards
At the 2019 EBMLive conference (see box 1), we wanted to better understand the problems and challenges that EMCRs encounter. In particular, we focused on EMCRs in those LMICs undergoing major health system transformations, such as Brazil and India. We asked the six recipients of the Building Capacity Bursaries (all co-authors of this commentary) to describe the challenges that they have encountered individually and among their peers, along with potential solutions (see box 2). Their responses reflect healthcare professionals who practice in South America, Africa, the Middle East and Asia. While some challenges are specific to certain settings, we tried to identify, highlight and describe broad overarching themes.

7 January 2012 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
ASAugusto C. S. Santos
Augusto C. S. Santos
ELEleonora M. Lima
Eleonora M. Lima
MPMaria Goretti M. G. Penido
Maria Goretti M. G. Penido
KSKatia D. Silveira
Katia D. Silveira
MTMauro Martins Teixeira
Mauro Martins Teixeira
ASAna Cristina Simões e Silva
Ana Cristina Simões e Silva